Cargando…

T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma

Detalles Bibliográficos
Autores principales: Postow, Michael, Manuel, Manuarii, Wong, Phillip, Yuan, Jianda, Noel, Marlene, Courtier, Anais, Pasqual, Nicolas, Wolchok, Jedd D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288372/
http://dx.doi.org/10.1186/2051-1426-2-S3-O8
_version_ 1782351957788196864
author Postow, Michael
Manuel, Manuarii
Wong, Phillip
Yuan, Jianda
Noel, Marlene
Courtier, Anais
Pasqual, Nicolas
Wolchok, Jedd D
author_facet Postow, Michael
Manuel, Manuarii
Wong, Phillip
Yuan, Jianda
Noel, Marlene
Courtier, Anais
Pasqual, Nicolas
Wolchok, Jedd D
author_sort Postow, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-4288372
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42883722015-01-15 T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma Postow, Michael Manuel, Manuarii Wong, Phillip Yuan, Jianda Noel, Marlene Courtier, Anais Pasqual, Nicolas Wolchok, Jedd D J Immunother Cancer Oral Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288372/ http://dx.doi.org/10.1186/2051-1426-2-S3-O8 Text en Copyright © 2014 Postow et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Postow, Michael
Manuel, Manuarii
Wong, Phillip
Yuan, Jianda
Noel, Marlene
Courtier, Anais
Pasqual, Nicolas
Wolchok, Jedd D
T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
title T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
title_full T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
title_fullStr T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
title_full_unstemmed T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
title_short T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
title_sort t cell receptor diversity evaluation to predict patient response to ipilimumab in metastatic melanoma
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288372/
http://dx.doi.org/10.1186/2051-1426-2-S3-O8
work_keys_str_mv AT postowmichael tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT manuelmanuarii tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT wongphillip tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT yuanjianda tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT noelmarlene tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT courtieranais tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT pasqualnicolas tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma
AT wolchokjeddd tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma